Operant response suppression induced with systemic administration of 5-hydroxytryptophan is centrally mediated

Eric A. Engleman,James M. Murphy,Feng C. Zhou,Morris H. Aprison,Joseph N. Hingtgen

DOI: https://doi.org/10.1016/0091-3057(95)00123-E

IF: 3.697

1995-01-01

Pharmacology Biochemistry and Behavior

Abstract:Intracerebroventricular (ICV) administration of selective serotonergic agents was used to examine the extent of central mediation of 5-HTP-induced operant response suppression in rats. ICV administration of LY53857 (1.0, 3.75, or 7.5 mu g/5 mu l/5 min) dose dependently blocked response suppression induced with systemically administered 5-HTP (25 mg/kg, IP), whereas ICV 0.9% saline (5 mu l over 5 min) had no significant effect on 5-HTP-induced response suppression. ICV ketanserin (7.5 mu g/5 mu l/5 min) also blocked response suppression induced with systemically administered 5-HTP. ICV administration of the 5-HT2A/2C receptor agonist DOI (80 mu g/5 mu l/5 min) induced significant periods of response suppression in this model, which was blocked with LY53857 (1.0 mg/kg, IF) pretreatment. These data demonstrate that central administration of 5-HT2A/2C antagonists potently attenuate operant response suppression induced with systemically administered 5-HTP or DOI and are in agreement with previous findings suggesting central mediation of 5-HTP-induced operant response suppression.